A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,600 shares of BHC stock, worth $108,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,600
Previous 36,200 67.96%
Holding current value
$108,460
Previous $384,000 79.17%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $150,060 - $256,086
-24,600 Reduced 67.96%
11,600 $80,000
Q1 2024

May 15, 2024

SELL
$7.77 - $10.61 $334,887 - $457,291
-43,100 Reduced 54.35%
36,200 $384,000
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $54,199 - $68,309
-8,300 Reduced 9.47%
79,300 $635,000
Q3 2023

Nov 14, 2023

SELL
$7.69 - $9.71 $164,566 - $207,794
-21,400 Reduced 19.63%
87,600 $720,000
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $262,548 - $403,920
-45,900 Reduced 29.63%
109,000 $872,000
Q1 2023

May 15, 2023

SELL
$6.28 - $9.85 $366,752 - $575,240
-58,400 Reduced 27.38%
154,900 $1.25 Million
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $307,545 - $400,465
-50,500 Reduced 19.14%
213,300 $1.34 Million
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $328,844 - $661,278
-71,800 Reduced 21.39%
263,800 $1.82 Million
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $1.22 Million - $4.07 Million
-172,200 Reduced 33.91%
335,600 $2.81 Million
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $4.38 Million - $5.64 Million
202,800 Added 66.49%
507,800 $11.6 Million
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $6.37 Million - $8.03 Million
-276,800 Reduced 47.58%
305,000 $8.42 Million
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $17.1 Million - $20.5 Million
-682,600 Reduced 53.99%
581,800 $16.2 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $17.8 Million - $21.2 Million
648,000 Added 105.13%
1,264,400 $37.1 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $7.9 Million - $12.7 Million
369,900 Added 150.06%
616,400 $19.6 Million
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $3.46 Million - $4.78 Million
-226,100 Reduced 47.84%
246,500 $5.13 Million
Q3 2020

Nov 16, 2020

SELL
$14.88 - $20.13 $5.14 Million - $6.95 Million
-345,300 Reduced 42.22%
472,600 $7.34 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $491,139 - $756,819
-36,900 Reduced 4.32%
817,900 $15 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $1.92 Million - $4.47 Million
-147,700 Reduced 14.73%
854,800 $13.2 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $9.36 Million - $15.8 Million
495,382 Added 97.69%
1,002,500 $30 Million
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $34.4 Million - $42.3 Million
-1,647,200 Reduced 76.46%
507,118 $11.1 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $10.9 Million - $14.1 Million
-532,029 Reduced 19.8%
2,154,318 $54.3 Million
Q1 2019

May 15, 2019

BUY
$20.23 - $26.29 $28.5 Million - $37.1 Million
1,409,579 Added 110.4%
2,686,347 $66.4 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $12.9 Million - $20.7 Million
730,250 Added 133.62%
1,276,768 $23.6 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $11.3 Million - $14 Million
546,518 New
546,518 $14 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.38B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.